NeuExcell Therapeutics
Phase 1NeuExcell Therapeutics is a clinical-stage gene therapy company developing first-in-class treatments for neurodegenerative diseases. We are advancing three pioneering clinical trials in glioma, Alzheimer's disease, and stroke. Our proprietary ATN Astrocytes To Neurons™ platform converts supporting glial cells into functional neurons, repairing damaged brain tissue at the injury sites. This breakthrough approach has the potential to address a wide range of conditions, from stroke and Alzheimer...
About
NeuExcell Therapeutics is a clinical-stage gene therapy company developing first-in-class treatments for neurodegenerative diseases. We are advancing three pioneering clinical trials in glioma, Alzheimer's disease, and stroke. Our proprietary ATN Astrocytes To Neurons™ platform converts supporting glial cells into functional neurons, repairing damaged brain tissue at the injury sites. This breakthrough approach has the potential to address a wide range of conditions, from stroke and Alzheimer...
Funding History
2Total raised: $20M
Company Info
Contact
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile